Stock price when the opinion was issued
MASI is a $5.4B company, which has declined ~32% year-to-date and 31% on a one-year basis. It missed on both sales and estimates in its recent quarter, and management noted it was displeased with results. Reduced guidance was led by assumptions of impatient volumes not returning to levels that management expected and it is not receiving some of the new large orders it anticipated. It trades at a 2.5X forward sales and 27.8X forward earnings multiple, which are both below its 10-year average. Relative to some of its peers, it trades at a cheaper P/E and price-to-sales valuation, but its forward sales and growth estimates are also weak relative to peers. We are not big fans of its negative momentum and poor guidance from management - we would prefer to see a shift in momentum with sales orders before getting more comfortable with the name.
Unlock Premium - Try 5i Free